C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 19/00 (2006.01) A61K 39/21 (2006.01) A61K 39/385 (2006.01) C07K 14/16 (2006.01) C07K 14/74 (2006.01) C07K 16/10 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2262427
A heteroconjugate is formed by linking a T cell binding ligand (TCBL) such as Peptide J of .beta.-2 microglobulin to a modified HGP-30 antigenic peptide fragment of p17 gag peptide, such as, for example (I). The heteroconjugate is effective in eliciting a TH1 directed immune response and provides a vaccine composition for treating or preventing AIDS.
On a formé un hétéroconjugué en liant un ligand de fixation d'un lymphocyte T (TCBL), tel qu'un peptide J d'une microglobuline .beta.-2, à un fragment peptidique antigénique HGP-30 modifié du peptide p17 gag, comme par exemple (I). Cet hétéroconjugué est efficace pour déclencher une réponse immune dirigée de TH1 et constitue une composition vaccinale destinée à traiter ou prévenir le SIDA.
Sarin Prem S.
Zimmerman Daniel H.
Blake Cassels & Graydon Llp
Cel-Sci Corporation
LandOfFree
Conjugated peptides, immunological reagent containing same... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugated peptides, immunological reagent containing same..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugated peptides, immunological reagent containing same... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1354567